Results 1 to 10 of about 22,759 (160)

Evolutionary genomics of KPC-2-producing Serratia marcescens and characterization of a novel bla KPC−2-harboring plasmid [PDF]

open access: yesBMC Microbiology
Background Serratia marcescens is a common opportunistic pathogen in hospitals. Its carbapenem-resistant strains, especially those carrying the bla KPC−2 gene, pose a serious challenge to clinical infection treatment. Methods In this study, we identified
Yali Zheng   +9 more
doaj   +4 more sources

Ginkgolic Acid as a carbapenem synergist against KPC-2 positive Klebsiella pneumoniae [PDF]

open access: yesFrontiers in Microbiology
The successful evolution of KPC-2 in bacteria has limited the clinical practice of carbapenems. This dilemma deteriorated the prognosis of associated infections and hence attracted increasing attention from researchers to explore alternative therapeutic ...
Yuping Song   +8 more
doaj   +4 more sources

Characterization of Corosolic Acid as a KPC-2 Inhibitor That Increases the Susceptibility of KPC-2-Positive Bacteria to Carbapenems [PDF]

open access: yesFrontiers in Pharmacology, 2020
The emergence of KPC-producing Gram-negative bacteria in clinical practice highlights the need to search for novel antimicrobials and new anti-infection strategies. In this study, we constructed a laboratory KPC-2-positive strain, E.
Yonglin Zhou   +10 more
doaj   +3 more sources

Investigating the prevalence of KPC-2 and the variant KPC-144 in carbapenem-resistant Klebsiella pneumoniae and elucidating its molecular epidemiological and genetic characteristics [PDF]

open access: yesBMC Microbiology
Background Klebsiella pneumoniae is responsible for nosocomial infections, and the prevalence of bla KPC and its variants, including bla KPC−2 and bla KPC−144, contributes to antibacterial resistance.
Kaichun Lin   +3 more
doaj   +2 more sources

Phosphate sensitivity of KPC-2: a hidden variable in β-lactamase kinetics. [PDF]

open access: yesAntimicrob Agents Chemother
ABSTRACT The catalytic activity of β-lactamases, particularly class A enzymes like KPC-2, is central to β-lactam antibiotic resistance. While phosphate buffers are widely used in enzymatic assays due to their physiological relevance, their potential to interfere with enzyme function remains ...
Ngango DF, Birgy A, Palzkill T.
europepmc   +3 more sources

The transferability and evolution of NDM-1 and KPC-2 co-producing Klebsiella pneumoniae from clinical settings

open access: yesEBioMedicine, 2020
Background: Emergence of KPC-2 and NDM-1-coproducing carbapenem-resistant Klebsiella pneumoniae (KPC-2-NDM-1-CRKP) has escalated threat of CRKP to healthcare. Currently, only 4 isolates had been reported sporadically.
Longyang Jin, Hua Gao
exaly   +3 more sources

Shifting of bla KPC−2 to bla KPC−90 in a sequence type 11 Klebsiella pneumoniae strain before the use of ceftazidime-avibactam [PDF]

open access: yesBMC Genomics
Background Klebsiella pneumoniae continues to be a problem worldwide. This study aimed to elucidate the evolution of a K. pneumoniae strain from harbouring bla KPC−2 to bla KPC−90. Methods Three K.
Dakang Hu   +8 more
doaj   +2 more sources

Emergence and clonal dissemination of KPC-2- and NDM-1-coharboring Citrobacter freundii in China with an IncR plasmid [PDF]

open access: yesMicrobiology Spectrum
The rise of carbapenem-resistant Enterobacteriaceae coharboring KPC-2 and NDM-1 poses a significant public health threat. KPC-2-NDM-1-Citrobacter freundii is rarely reported in clinical settings. In this study, we report the largest cohort of eight KPC-2-
Juanjuan Zhou   +5 more
doaj   +2 more sources

Ceftazidime–Avibactam in Combination with Imipenem as Salvage Therapy for ST11 KPC-33-Producing Klebsiella pneumoniae

open access: yesAntibiotics, 2022
A 22-year-old man, after a hematopoietic stem cell transplant, suffered long-term pneumonia caused by blaKPC-2-positive K. pneumoniae and blaKPC-33-positive K.
Li Ding   +5 more
doaj   +1 more source

Elucidating the role of Trp105 in the KPC‐2 β‐lactamase [PDF]

open access: yesProtein Science, 2010
AbstractThe molecular basis of resistance to β‐lactams and β‐lactam‐β‐lactamase inhibitor combinations in the KPC family of class A enzymes is of extreme importance to the future design of effective β‐lactam therapy. Recent crystal structures of KPC‐2 and other class A β‐lactamases suggest that Ambler position Trp105 may be of importance in binding β ...
Krisztina M, Papp-Wallace   +6 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy